Harvard Bioscience Cash Flow - Quarterly (NASDAQ:HBIO)

Add to My Stocks
$3 $0 (0%) HBIO stock closing price Aug 18, 2017 (Closing)

For analyzing any company like Harvard Bioscience from an investment perspective, its important to check the cash flow statement. Financials statements like the income statement and balance sheet show that the company has Harvard Bioscience profits and Harvard Bioscience debt, while the cash flow statement provides details of cash flow movments. Harvard Bioscience had cash and cash equivalents of $6.74M at beginning of quarter and $4.72M at quarter end for 2017-Q2. Harvard Bioscience cash flow analysis tells whether or not the company has enough cash for its day to day activities, and for investing for future growth. The cash from operating activities for Harvard Bioscience is $-0.14MĀ for 2017-Q2, which saw an increase of -77.05% from previous quarter. View details of Harvard Bioscience cash flows for latest & last 40 quarters.

show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec.2017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q1
Harvard Bioscience Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow1.91M0.93M4.36M3.35M2.24M1.09M4.65M3.36M2.27M1.17M
Net Increase (Decrease) in Assets Liabilities-2.29M-1.32M-0.04M-0.47M-2.37M-1.98M-2.71M-3.49M-2.4M-0.62M
Cash From (used in) Discontinued Operations----------
Other Adjustments Net1.69M0.84M5.36M3.75M1.7M0.79M17.8M0.97M0.19M0.35M
Harvard Bioscience Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment-0.44M-0.19M-1.44M-0.92M-0.4M-0.2M-2.95M-2.29M-1.62M-1.04M
Acquisition Disposition of Subsidiaires--1.41M----4.54M-4.54M-4.54M-4.54M
Increase (Decrease) in Investments----------
Other Cash Inflow (Outflow) from Investment Activities-0.04M-0.03M-0.03M-0.03M-0.01M--0.01M---
Harvard Bioscience Net Cash from (used by) Invesment Activities
Issuance (Purchase) of Equity Shares-0.08M-0.15M0.18M0.08M-0.01M-0.11M2.04M1.95M1.86M0.38M
Issuance (Repayment) of Debt Securities-0.55M-0.11M-5.05M-3.73M-2.62M-1.61M5.8M-1.3M-0.79M0.45M
Increase (Decrease) in Bank & Other Borrowings-------8.35M---
Payment of Dividends & Other Cash Distributions----------
Other Cash from (used by) Financing Activities-------0.03M-0.03M-0.03M-
Harvard Bioscience Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash0.37M0.1M-1.6M-0.44M-0.28M0.08M-0.03M-0.76M-0.61M-0.84M
Harvard Bioscience Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year6.74M14.13M25.77M20.68M17.91M19.7M16.58M13.69M18.2M9.75M
Cash & Equivalents at Year End4.72M4.59M5.59M5.34M3.63M4.17M6.74M6.09M7.4M8.03M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters
Get Cash flow for another ticker

While Harvard Bioscience stock price history provides the price history of a stock, Harvard Bioscience stock comparison chart shows the same in comparison to peers, and cash flow statements provide cash position of the company. Common terms used in the statement of cash flows are:
  • Harvard Bioscience had a Net Change in Cash and Cash Equivalents of $-0.87M for the latest quarter 2017-Q2. If a firm is able to grow its cash, it is considered to be a positive signal and could lead to a jump in the Harvard Bioscience stock price , albeit too much cash on hand can imply the company has no or limited avenues for growth in which to invest this cash.
  • Cash Flow from operating activities: Operating activities include the core business activities. This line item refers to the cash generated from the same and stood at a negative value of $-0.14M for HBIO.
  • Cash Flow from investment activities: Harvard Bioscience used $0.26M cash due to investment activities. It includes the use of cash outside of normal day to day activities like buying fixed assets, plant and machinery etc.
  • Cash Flow from financing activities: Financing activities include the cash that comes into a company in the form of loans or interest earned or shareholders money, as well as the cash that goes out. Harvard Bioscience spent $0.37M from financing activities,in the form of repayment of loans or interest paid, dividend pay-out to shareholders etc.